Waters Corp

  • Industrials
  • Biotechnology: Laboratory Analytical Instruments
  • www.waters.com
  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $22.78B
  • PE 37
  • Debt $1.83B
  • Cash $330.51M
  • EV $24.28B
  • FCF $620.14M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$622.64M
EBIT$798.31M
ROE39%
ROA18%
FCF$620.14M
Equity$1.60B
Growth Stability4%
PE36.59
PEG2.55
PB14.21
P/FCF36.73
P/S7.84
Price/Cash0.01
Debt/Equity1.14
Debt/FCF2.94
Net Margins19%
Op. Margins27%
Earnings CAGR1%
Sales Growth YoY4%
Sales Growth QoQ4%
Sales CAGR-2%
FCF CAGR-0%
Equity CAGR-8%
Earnings Stability0
Earnings Growth YoY20%
Earnings Growth QoQ13%
Earnings CAGR 5Y14%
Sales CAGR 5Y22%
FCF CAGR 5Y10%
Equity CAGR 5Y51%
Earnings CAGR 3Y161%
Sales CAGR 3Y161%
Equity CAGR 3Y79%
Market Cap$22.78B
Revenue$2.91B
Assets$4.51B
Total Debt$1.83B
Cash$330.51M
Shares Outstanding59.31M
EV24.28B
Earnings Score6%
Moat Score96%
Safety Score59%
Final Score54%
Working Capital831.68M
Current Ratio2.02
Shares Growth 3y-0%
Equity Growth QoQ14%
Equity Growth YoY77%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2020, Waters generated 59% from pharmaceutical customers, 30% from industrial clients, and 11% from academic/government institutions.

SEC Filings

Direct access to Waters Corp (WAT) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 28
    • 10-Q Jun 29
    • 10-Q Mar 30
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jul 01
    • 10-Q Apr 01
  • 2022
    • 10-K Dec 31
    • 10-Q Oct 01
    • 10-Q Jul 02
    • 10-Q Apr 02

Sector Comparison

How does Waters Corp compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Waters Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 1%
Stability 0%
loading chart...

Waters Corp Discounted Cash Flow

Fully customizable DCF calculator online for Waters Corp .

= $6B
012345678910TV
fcf$620M$617M$614M$611M$608M$605M$602M$599M$596M$593M$590M$5.9B
DCF$561M$507M$459M$415M$376M$340M$307M$278M$252M$228M$2.3B
Value$6B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins22%23%24%1%25%25%22%25%24%22%19%
ROA-13%13%12%20%28%23%27%27%18%18%
ROE-23%23%1%38%-274%225%189%140%56%39%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF-3.623.57-2.263.732.44---2.94
Debt over Equity0.770.810.850.940.73-8.266.54.143.232.11.14
Growth Stability---4%100%100%100%100%100%100%4%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-3%6%7%5%-1%-2%18%7%-1%22%
Earnings YoY growth-9%11%-96%3K%-0%-12%33%2%-9%14%
Equity YoY growth-9%12%-3%-30%-114%-207%58%37%128%51%
FCF YoY growth-9%19%12%-17%-6%29%-5%-26%1%10%